CNS
WCG Clinical | Insights
When should a child assent form be used in a pediatric clinical trial?
Blog Posts
WCG Clinical | Insights
Providing Research Participants with New Information: Is “Re-Consent” Always Necessary?
Whitepapers
WCG Clinical | Insights
May I pay a physician for referring a patient to our study?
Blog Posts
WCG Clinical | Insights
Regulatory Challenges in Pediatric Drug Development: The European Perspective
Blog Posts
WCG Clinical | Insights
90 Second Insights: Transforming Depression Trials During COVID-19—and Beyond
Videos
WCG Clinical | Insights
90 Second Insights: Transforming Psychiatric Disorder Trials During COVID-19—and Beyond
Videos
WCG Clinical | Insights
90 Second Insights: Transforming Schizophrenia Trials During COVID-19—and Beyond
Videos
WCG Clinical | Insights
How a Top 25 Pharma Company Reduced the Placebo Response for their Phase II Study
Case Studies
WCG Clinical | Insights
Submitting Deviations from a Sponsor’s Adverse Event Reporting Requirements to the IRB
Blog Posts
WCG Clinical | Insights